Inventor · disambiguated record
Masaki Daini
Also filed as: DAINI MASAKI
16 granted patents·6 pending applications·47 citations·filing 2013–2023
91Inventor score
Top patents by PatentIndex Score
22 records- 0193US9487511B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Nov 8, 2016·5 cites·2 claims
- 0289US11059780B2Substituted pyrrolidine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jul 13, 2021·4 cites·13 claims
- 0389US10807987B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 20, 2020·5 cites·8 claims
- 0489US10053456B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 21, 2018·3 cites·7 claims
- 0587US11319286B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 3, 2022·4 cites·10 claims
- 0687US11034700B2Substituted pyrrolidine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jun 15, 2021·4 cites·13 claims
- 0787US10406146B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 10, 2019·4 cites·11 claims
- 0886US2024317733A1Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0985US9371320B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jun 21, 2016·10 cites·8 claims
- 1084US11702419B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jul 18, 2023·1 cites·18 claims
- 1183US10357484B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 23, 2019·2 cites·13 claims
- 1283US10081624B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Sep 25, 2018·5 cites·14 claims
- 1375US10968213B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 6, 2021·0 cites·1 claims
- 1475US2021179603A1Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1570US10414761B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 17, 2019·0 cites·1 claims
- 1666US9920047B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Mar 20, 2018·0 cites·1 claims
- 1750US2023348435A11-((1h-pyrazol-4-yl)methyl)-3-(phenyl)-1,3-dihydro-2h-imidazol-2-one derivatives and related compounds as gpr139 antagonists for the treatment of e.g. depressionTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1849US2022289679A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 1943US2022089525A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 2043US2016251352A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Application pending·0 cites
- 2142US11459325B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 4, 2022·0 cites·10 claims
- 2237US10308643B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 4, 2019·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Masaki Daini files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →